Biotech 2050 Podcast

podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

#185 US · Overall 265 recordings 2019 → today Every two weeks updated 5 days ago
Search in Biotech 2050 Podcast →

All episodes

141–160 of 265
124. Leukemia and beyond: Next-gen precision cell therapy, Ivan Dimov, Co-Founder & CEO, Orca Bio contributed by Lukas · Oct 26, 2022
123. Nano-rare patients & rare diseases, Stanley Crooke, Founder & CEO, n-Lorem Foundation contributed by Lukas · Oct 19, 2022
122. New vision for cell & gene therapy, Andrew Sandford & Michael Paglia, ElevateBio BaseCamp contributed by Lukas · Oct 12, 2022
121. Mission-driven biotech investing, Josh Wolfe, Co-founder & Managing Partner, Lux Capital contributed by Lukas · Oct 5, 2022
120. Beyond CD8 immuno-oncology, Amanda Wagner, President and CEO, Immunitas Therapeutics contributed by Lukas · Sep 28, 2022
119. Special Edition: Quiet Leader, Loud Results, Ankit Mahadevia, Author contributed by Lukas · Sep 21, 2022
118. One team, one mission: tackling pruritus, Chris Posner, President & CEO, Cara Therapeutics contributed by Lukas · Sep 14, 2022
117. Pioneering cell biology drug discovery, Rachel Meyers, CSO, Faze Medicines contributed by Lukas · Aug 31, 2022
116. Retinal restoration and visions for growth, Brian Culley, CEO, Lineage Cell Therapeutics contributed by Lukas · Aug 24, 2022
115. Innovations in diabetes therapies, Timothy Kieffer, CSO, Manasi Sinha Jaiman, CMO, ViaCyte contributed by Lukas · Aug 17, 2022
114. Advancing cell therapy and multiple myeloma treatment, Ying Huang, CEO, Legend Biotech contributed by Lukas · Aug 10, 2022
113. Envisioning VDC cancer treatment, Elisabet de los Pinos, CEO, Aura Biosciences contributed by Lukas · Aug 3, 2022
112. New approaches in CNS diseases, Brad Margus, Co-founder and Executive Chairman, Cerevance contributed by Lukas · Jul 27, 2022
111. Synthetic biology & probiotics, Aoife Brennan, President & CEO, Synlogic contributed by Lukas · Jul 20, 2022
110. Novel cell and gene therapies, Mark Gergen, CEO, Poseida Therapeutics, Inc. contributed by Lukas · Jul 13, 2022
109. Gene therapy CDMO, Tim Miller, CEO, Erandi De Silva, SVP of Prod. Dev., Forge Biologics contributed by Lukas · Jun 29, 2022
108. Vibe Bio launches to transform drug development, Alok Tayi Ph.D. and Susanna Harris Ph.D. contributed by Lukas · Jun 22, 2022
107. Fighting infectious diseases with biologics, Paul Garofolo, Co-founder & CEO, Locus Biosciences contributed by Lukas · Jun 15, 2022
106. Next-Gen CRISPR applications, Trevor Martin, Co-founder & CEO, Mammoth Biosciences contributed by Lukas · Jun 8, 2022
105. Gene therapy in hearing loss, Laurence Reid, PhD, CEO, Decibel Therapeutics contributed by Lukas · Jun 1, 2022
page 8 of 14 «« ← Prev Next → »»

Charts

module · podcast

#185 Overall · United States

🇲🇽 #37 · 🇧🇪 #38 · 🇫🇮 #42 · 🇮🇳 #89 · 🇷🇺 #125 · 🇰🇷 #126 · 🇨🇭 #140 · 🇳🇱 #145 · 🇫🇷 #152 · 🇿🇦 #155 · +19 more

charted in 30 countriesFull rankings →

Activity

module · podcast

2 episodes · last 30 days

Wed 11Thu 6Tue 5

Episodes per week over the last six months.

About

module · podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Biotech 2050 biotech2050.com RSS Apple